BLCO News and Press, Bausch + Lomb Corporation From 02/21/24

Vimeo Inc. (VMEO) is expected to report $-0.01 for Q4 2023 Heineken N.V ADR (HEINY) is expected to report for Q4 2023 American States Water Company (AWR) is expected to report $0.53 for Q4 2023 NextPlay Technologies Inc. (NXTP) is expected to report for Q3 2024 Inseego Corp. (INSG...

2024-02-20 13:18:35 ET More on Bausch + Lomb Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound Eminence Capital adds Sea, AMD stakes; exits Peloton, Bausch + Lomb in Q4 Bausch + Lomb draws double downgrade at J.P. Morgan on spinoff concerns ...

2024-02-14 11:49:54 ET More on Advanced Micro Devices, Uber, etc. SentinelOne rises after BofA upgrades on industry tailwinds, improving macro AMD: I Am Not Ready To Pay Premium For The GPU Laggard AI semiconductor market is expected to surge to $119B by 2027 - Deuts...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2023 financial results on Wednesday, Feb. 21, 2024. Bausch + Lomb will host a conference call and live webcast at 8 ...

2024-01-31 06:23:00 ET Summary Bausch + Lomb is a top company in the global eye health care industry, with over 400 products and operations in over 100 countries. The company is focused on its core business of vision care, ophthalmic pharmaceuticals, and surgical equipment. De...

2024-01-28 04:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-26 08:51:01 ET More on Bausch + Lomb Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch + Lomb Corporation (BLCO) Q3 2023 Earnings Call Transcript Bausch + Lomb drops amid comments at JPMorgan Healthcare Conference Bausch + Lomb wins FDA ...

2024-01-17 05:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...

2024-01-08 16:17:29 ET More on Bausch + Lomb Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade) Bausch + Lomb Corporation (BLCO) Q3 2023 Earnings Call Transcript Bausch + Lomb wins FDA nod for eye surgery product Bausch + Lomb Non-GAAP EPS of $0.22 beat...